Sectors

Allied Minds had invested over $50m in New York University RAM technology spinout Spin Memory, which has decided to liquidate its assets to pay creditors.

GV notched up an exit as cancer therapy developer Monte Rosa Therapeutics priced an upsized initial public offering at the top of its range.

DNA Capital has returned to lead a $59.5m round for the Qualcomm Ventures-backed digital prescription startup.

Applied Materials and Arm were among the investors in RAM technology developer Spin Memory, which has elected to liquidate its assets to pay creditors.

BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.

Poste Italiane, SEB, PayPal, ABN Amro, BNP Paribas, Nordnet and Nordea are set to exit the open banking platform developer in a $2.1bn purchase by Visa.

Novo and Orlando Health helped the haemodialysis technology provider increase its overall funding to $350m since it was spun off by IMI.

Harvard-aligned venture capital firm Xfund has reinvested in ImmuneID, which is developing precision immunology therapies based on Harvard University and Johns Hopkins University research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Oshri Kaplan, director, Munich Re Ventures

MIT mRNA therapeutics spinout Strand has secured series A funding from BeiGene, Redmile Group, Camford Capital, Playground Global and Anri.